Novavax Says its Covid-19 Vaccine is 89.3 Percent Effective A | Read Less - Know All

Novavax Says its Covid-19 Vaccine is 89.3 Percent Effective

An experimental coronavirus vaccine developed by the biotech company Novavax is 89.3 percent effective at preventing Covid-19, the company announced Thursday. Results from Novavax’s Phase 3 trial in the United Kingdom demonstrated the vaccine candidate’s efficacy and showed that it protected against the U.K. variant of the virus. Results from another trial, in South Africa, showed that it was also effective against the variant that emerged there, although efficacy was lower.


@ReadLessKnowAll